Which Finance & Investments - CV Finance Stocks Are Deep Value Picks in Week of Jun 27, 2026?

Sector Pulse

The CV Finance sector, represented in this analysis solely by Shriram Finance (SHRIRAMFIN), is undergoing a massive structural transformation. The demand environment is rated as elevated, underpinned by management's explicit target to accelerate growth to the 18%-20% range. The defining event of the quarter is not the standard quarterly PAT or EBITDA metrics—which were deliberately Not Given in favor of broader structural updates—but rather a landmark capital infusion that fundamentally alters the balance sheet and competitive positioning of the constituent.

Catalysts Playing Out Across the Pack

The dominant catalyst actively reshaping the sector is Management Or Ownership Change. This is driven entirely by MUFG's agreement to take a 20% stake in SHRIRAMFIN via a professional allotment for US$4.4 billion. This massive equity injection directly triggers the Interest Cost Reduction Deleveraging catalyst. Management explicitly projects a 100 basis point advantage on borrowing costs over the next two years as gearing decreases from 4.3 to 2.6. Furthermore, this deleveraging sets the stage for a clear Operating Leverage Inflection, with the company targeting an ROA expansion from the current 2.8 to 3.6 over a five-year period. We are also tracking early, emerging signs of Market Share Gains and Asset Quality Improvement. The company plans to double its new vehicle market share from 3% to 6% over three years, while anticipating a 10 to 20 basis point improvement in credit costs due to enhanced customer retention capabilities.

What Managements Are Guiding

Forward guidance is overwhelmingly CONFIDENT, focusing on long-term structural metrics rather than immediate quarterly beats. SHRIRAMFIN is targeting an accelerated top-line growth rate of 18%-20%, a step up from its historical 16%-17% trajectory. While long-term ROA is guided to expand to 3.6, near-term ROE guidance was LOWERED to 13.5% for the next year. Management clarified this is a mathematical consequence of the enlarged equity base following the US$4.4 billion capital infusion, rather than any operational deterioration. Net Interest Margin (NIM) is expected to expand, supported by the aforementioned 100 basis point borrowing cost reductions, which will more than offset any potential lower lending rates in the market.

Shared Risks (9-type taxonomy)

The primary risk exposure falls squarely under the regulatory taxonomy. The US$4.4 billion MUFG transaction is strictly contingent upon formal RBI and CCI approvals. While management expects clearance within two to three months, they have provided an outer limit extending to April 2026, introducing a medium-severity timeline risk to the capital infusion. Additionally, a low-severity geopolitical risk is emerging regarding US tariffs. Management noted caution regarding MSME segments that are dependent on the US market, as some segments have up to 60% exposure to US trade dynamics.

Bottom Line

The sector outlook is highly bullish, anchored entirely by SHRIRAMFIN's balance sheet transformation. The influx of US$4.4 billion de-risks the liability side and provides immense firepower for market share expansion in the new vehicle segment. If regulatory approvals proceed smoothly by April 2026, the resulting cost of funds advantage will create a formidable competitive moat, driving the projected ROA expansion to 3.6.